Studysummary In this study, alopecia areata was associated with a statistically significant reduction in melanoma incidence, but not in overall skin cancer risk, highlighting the need for cautious interpretation due to heterogeneity.
Read the full study on frontiersin.org →
Research cited in this study 10
- Evaluating Current and Emerging JAK Inhibitors for Alopecia Areata: A Narrative Review Dermatology and Therapy · 2025
- Rates of Infections, Malignancies, Cardiovascular Outcomes, and Death in Individuals with Hospital-Treated Alopecia Areata: A Registry-Based Cohort Study in Denmark Acta Dermato Venereologica · 2025
- IL-15 in T-Cell Responses and Immunopathogenesis Immune Network · 2024
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review Dermatology and therapy · 2023
- Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database Dermatology and therapy · 2023
- A Comprehensive Literature Review of JAK Inhibitors in the Treatment of Alopecia Areata Clinical, cosmetic and investigational dermatology · 2021
- Hair Follicle Immune Privilege and Its Collapse in Alopecia Areata Experimental dermatology · 2020
- Cancer Risk by the Subtype of Alopecia Scientific Reports · 2018
- Cancer Risk in Patients with Alopecia Areata: A Nationwide Population-Based Matched Cohort Study Cancer Medicine · 2018
- Alopecia Areata: What’s New in Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Options? Journal of dermatological science · 2016